-transparent.png){kind=logo}
Hepatocyte growth factor (HGF) induced motility of cultured mouse keratinocytes (308R cells). This HGF-induced cell motility was inhibited by microinjection of either rho GDI, an inhibitory GDP/GTP exchange protein for rho p21 small GTP-binding protein, or a botulinum exoenzyme C3 which is known to selectively impair the function of rho p21 by ADP-ribosylating its effector domain. The rho GDI action was prevented by comicroinjection with the guanosine 5'-(3-0-thio)triphosphate (GTP gamma S)-bound active form of rhoA p21, and the C3 action was prevented by comicroinjection with a rhoA p21 mutant (rhoAIle41 p21) which is resistant to the C3 action. The HGF-induced cell motility was not inhibited by microinjection of a dominant negative rac1 p21 mutant (rac1Asn17 p21) or a dominant negative Ki-ras p21 mutant (Ki-rasAsn17 p21). Microinjection of the GTP gamma S-bound form of rac1 p21 or a dominant active Ki-ras p21 mutant (Ki-rasVal12 p21) did not induce cell motility. These results indicate that both rho p21 and rho GDI, but neither rac p21 nor ras p21, are involved in the HGF-induced cell motility. However, microinjection of the GTP gamma S-bound form of rhoA p21 alone did not induce cell motility in the absence of HGF, suggesting that activation of rho p21 is necessary but not sufficient for the HGF-induced cell motility. The HGF-induced cell motility was mimicked by 12-0-tetradecanoyl-phorbol-13-acetate, a protein kinase C-activating phorbol ester, but not by Ca2+ ionophore. The phorbol ester-induced cell motility was also inhibited by microinjection of rho GDI or C3. These results indicate that both rho p21 and rho GDI are also involved in the phorbol ester-induced cell motility.
K Takaishi, and
T Sasaki, and
M Kato, and
W Yamochi, and
S Kuroda, and
T Nakamura, and
M Takeichi, and
Y Takai
April 1995,
The Journal of biological chemistry,
K Takaishi, and
T Sasaki, and
M Kato, and
W Yamochi, and
S Kuroda, and
T Nakamura, and
M Takeichi, and
Y Takai
April 1992,
The Kobe journal of medical sciences,
K Takaishi, and
T Sasaki, and
M Kato, and
W Yamochi, and
S Kuroda, and
T Nakamura, and
M Takeichi, and
Y Takai
May 2000,
Molecular biology of the cell,
K Takaishi, and
T Sasaki, and
M Kato, and
W Yamochi, and
S Kuroda, and
T Nakamura, and
M Takeichi, and
Y Takai
November 1997,
The international journal of biochemistry & cell biology,
K Takaishi, and
T Sasaki, and
M Kato, and
W Yamochi, and
S Kuroda, and
T Nakamura, and
M Takeichi, and
Y Takai
January 1997,
Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
K Takaishi, and
T Sasaki, and
M Kato, and
W Yamochi, and
S Kuroda, and
T Nakamura, and
M Takeichi, and
Y Takai
June 1995,
Journal of cell science,
K Takaishi, and
T Sasaki, and
M Kato, and
W Yamochi, and
S Kuroda, and
T Nakamura, and
M Takeichi, and
Y Takai
February 1999,
The EMBO journal,
K Takaishi, and
T Sasaki, and
M Kato, and
W Yamochi, and
S Kuroda, and
T Nakamura, and
M Takeichi, and
Y Takai
February 1992,
The Kobe journal of medical sciences,
K Takaishi, and
T Sasaki, and
M Kato, and
W Yamochi, and
S Kuroda, and
T Nakamura, and
M Takeichi, and
Y Takai
September 1999,
Proceedings of the National Academy of Sciences of the United States of America,
K Takaishi, and
T Sasaki, and
M Kato, and
W Yamochi, and
S Kuroda, and
T Nakamura, and
M Takeichi, and
Y Takai
April 2001,
Investigative ophthalmology & visual science,
